Full Text View
Tabular View
No Study Results Posted
Related Studies
Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
This study is currently recruiting participants.
Verified by Monash University, March 2010
First Received: November 22, 2006   Last Updated: March 17, 2010   History of Changes
Sponsor: Monash University
Collaborators: Royal Brompton & Harefield NHS Foundation Trust
IM Medical Ltd, Melbourne
Information provided by: Monash University
ClinicalTrials.gov Identifier: NCT00403351
  Purpose

Estimating the risk of future cardiovascular events such as death, stroke and myocardial infarction using traditional risk factors (such as age, gender, smoking, diabetes, hyperlipidaemia and hypertension) is well accepted in patients with and without existing cardiovascular disease. These estimates are based on a number of robust observational studies, including the original Framingham study. While these methods apply reasonably well on a population level their application to the individual patients is not always straightforward. In addition, risk charts, such as those published by the Joint British Societies and American Heart Association, may underestimate risk in certain groups, notably diabetics and patients of Indo-Asian background, whilst overestimating risk in others (by as much as 50% in some studies).


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Correlation of Multiple Risk Factors With Presence and Severity of Coronary Artery Disease.

Resource links provided by NLM:


Further study details as provided by Monash University:

Biospecimen Retention:   Samples Without DNA

Serum specifically for future cardiac biomarkers


Estimated Enrollment: 750
Study Start Date: October 2006
Estimated Study Completion Date: May 2010
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
ARM-CAD 1
Cross-sectional analysis using coronary angiogram results
ARM-CAD 2
Prospective cohort for incident cardiovascular events and mortality

Detailed Description:

A number of variables including clinical, biochemical, and enzymatic have been evaluated to see if they add to conventional "risk-reduction" models such as Framingham and if so, to understand if they may be used in routine clinical practice.

The aim of this study is to assess several known and a few novel risk-factors (heart rate variability, pulse wave analysis, high-sensitivity CRP and BNP) prior to planned elective coronary angiography (cross-sectional analysis) and in a prospective cohort of high and low-risk patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

ARM-CAD 1: Patients attending elective coronary angiography ARM-CAD 2: Participants in ARM-CAD 1 plus volunteers with cardiac risk factors

Criteria

Inclusion Criteria:

  • Adults (18 years or older)
  • Male or Female

Exclusion Criteria:

  • Acute coronary syndrome
  • Urgent angiography
  • Assessment would constitute harm to patient
  • Informed consent not obtained
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00403351

Contacts
Contact: Dipak Kotecha, MB ChB MRCP +61 3 9903 0950 dipak.kotecha@med.monash.edu.au

Locations
Australia, Victoria
Box Hill Hospital (Eastern Health) Active, not recruiting
Box Hill, Victoria, Australia, 3128
Caulfield General Medical Centre Recruiting
Caulfield, Victoria, Australia
Principal Investigator: Dipak Kotecha, MBChB MRCP            
Northern Hospital (Northern Health) Active, not recruiting
Epping, Victoria, Australia, 3076
Alfred Hospital Active, not recruiting
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators
Monash University
Royal Brompton & Harefield NHS Foundation Trust
IM Medical Ltd, Melbourne
Investigators
Principal Investigator: Dipak Kotecha, MB ChB MRCP Monash University
Principal Investigator: David Eccleston, MBBS FRACP Monash University and Northern Hospital
Principal Investigator: Henry Krum, Professor Alfred Hospital / Monash University
  More Information

No publications provided by Monash University

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Responsible Party: Monash University ( Dr. Dipak Kotecha )
ClinicalTrials.gov Identifier: NCT00403351     History of Changes
Other Study ID Numbers: CP-02/04
Study First Received: November 22, 2006
Last Updated: March 17, 2010
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

Keywords provided by Monash University:
Risk
Coronary artery disease
Heart Rate variability
Pulse wave analysis
BNP
CRP

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on September 07, 2010